Analysis of disease-free survival (DFS) data demonstrated that cancers with high CDCA5 expression have a poor prognosis of ACC (P=6.6e-05), KIRC (P=0.043), KIRP (P=0.00028), LGG (P=0.0064), LIHC (P=0.00014), MESO (P=0.019), PAAD (P=0.025), PCPG (P=0.03), PRAD (P=0.00048), and THCA (P=0.012) (Figure 3C; Figure 3D). This evidence concerns the gene CDCA5 and cancer.